Neutron encoded mass tags for analyte quantification
US-11333669-B2 · May 17, 2022 · US
US11692983B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11692983-B2 |
| Application number | US-202117159923-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 27, 2021 |
| Priority date | Feb 13, 2013 |
| Publication date | Jul 4, 2023 |
| Grant date | Jul 4, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides reagents for instrumentation quality control and methods of use thereof. In particular, sets of peptides or other molecules are provided for evaluating the performance of instruments with mass spectrometry (MS) and/or liquid chromatography (LC) functionalities.
Opening claim text (preview).
The invention claimed is: 1. A peptide mixture comprising three or more distinct-mass versions of each of three or more distinct-sequence peptides, wherein two or more of the distinct-mass versions of each distinct-sequence peptide comprises one or more amino acids with above natural-abundance levels of one or more heavy isotopes, and wherein the distinct-sequence peptides: do not contain one or more of tryptophan, methionine, cysteine, proline, asparagine, glutamine, or histidine residues; and/or do not contain internal lysine or arginine residues. 2. The peptide mixture of claim 1 , wherein the distinct-mass versions of each distinct-sequence peptide are present at distinct concentrations. 3. The peptide mixture of claim 2 , wherein the peptides are present at concentrations ranging from 10 nM to 1 μM. 4. The peptide mixture of claim 3 , wherein the peptides are present at concentrations ranging from 1 nM (femtomoles per microliter) to 10 μM. 5. The peptide mixture of claim 1 , wherein the distinct-sequence peptides are separable by liquid chromatography based on their different hydrophobicities. 6. The peptide mixture of claim 1 , wherein the distinct-sequence peptides are separable by liquid chromatography based on their different charge, size, or hydrophilicity. 7. The peptide mixture of claim 1 , comprising 5-10 distinct-sequence peptides. 8. The peptide mixture of claim 1 , wherein the distinct-mass versions of any of the distinct-sequence peptides are differentiable by mass spectrometry. 9. The peptide mixture of claim 1 , wherein the distinct-mass versions of any of the distinct-sequence peptides are the result of different combinations of stable heavy isotope-labeled amino acids. 10. The peptide mixture of claim 9 , wherein each of the distinct-mass versions of any of the distinct-sequence peptides comprises a different number of uniformly stable isotope-labeled amino acids. 11. The peptide mixture of claim 1 , comprising 5-10 distinct-mass versions of each of the distinct-sequence peptides. 12. The peptide mixture of claim 1 , wherein the distinct-sequence peptides do not contain proline residues. 13. The peptide mixture of claim 1 , wherein the distinct-sequence peptides do not contain glutamine residues. 14. The peptide mixture of claim 1 , wherein the distinct-sequence peptides do not contain asparagine residues. 15. The peptide mixture of claim 1 , wherein the distinct-sequence peptides do not contain terminal aspartate residues. 16. The peptide mixture of claim 1 , wherein the distinct-sequence peptides do not contain terminal glutamate residues. 17. The peptide mixture of claim 1 , wherein the distinct-sequence peptides do not contain tryptophan residues. 18. The peptide mixture of claim 1 , wherein the distinct-sequence peptides do not contain methionine residues. 19. The peptide mixture of claim 1 , wherein the distinct-sequence peptides do not contain cysteine residues. 20. The peptide mixture of claim 1 , wherein the distinct-sequence peptides do not contain histidine residues.
Calibration of the apparatus · CPC title
for calibrating the measuring apparatus · CPC title
Liquid chromatography · CPC title
external · CPC title
involving peptides or proteins · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.